Risk factors for loss of residual renal function in children treated with chronic peritoneal dialysis
In dialyzed patients, preservation of residual renal function is associated with better survival, lower morbidity, and greater quality of life. To analyze the evolution of residual diuresis over time, we prospectively monitored urine output in 401 pediatric patients in the global IPPN registry who commenced peritoneal dialysis (PD) with significant residual renal function. Associations of patient characteristics and time-variant covariates with daily urine output and the risk of developing oligoanuria (under 100 ml/m(2)/day) were analyzed by mixed linear modeling and Cox regression analysis including time-varying covariates. With an average loss of daily urine volume of 130 ml/m(2) per year, median time to oligoanuria was 48 months. Residual diuresis significantly subsided more rapidly in children with glomerulopathies, lower diuresis at start of PD, high ultrafiltration volume, and icodextrin use. Administration of diuretics significantly reduced oligoanuria risk, whereas the prescription of renin-angiotensin system antagonists significantly increased the risk oligoanuria. Urine output on PD was significantly associated in a negative manner with glomerulopathies (-584 ml/m(2)) and marginally with the use of icodextrin (-179 ml/m(2)) but positively associated with the use of biocompatible PD fluid (+111 ml/m(2)). Children in both Asia and North America had consistently lower urine output compared with those in Europe perhaps due to regional variances in therapy. Thus, in children undergoing PD, residual renal function depends strongly on the cause of underlying kidney disease and may be modifiable by diuretic therapy, peritoneal ultrafiltration, and choice of PD fluid..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2015 |
|---|---|
| Erschienen: |
2015 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:88 |
|---|---|
| Enthalten in: |
Kidney international - 88(2015), 3, Seite 605-613 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ha, Il-Soo [VerfasserIn] |
|---|
| Links: |
Volltext |
|---|
| BKL: | |
|---|---|
| Themen: |
Children |
| doi: |
10.1038/ki.2015.108 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC1956476083 |
|---|
| LEADER | 01000caa a2200265 4500 | ||
|---|---|---|---|
| 001 | OLC1956476083 | ||
| 003 | DE-627 | ||
| 005 | 20230512205433.0 | ||
| 007 | tu | ||
| 008 | 160206s2015 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1038/ki.2015.108 |2 doi | |
| 028 | 5 | 2 | |a PQ20160617 |
| 035 | |a (DE-627)OLC1956476083 | ||
| 035 | |a (DE-599)GBVOLC1956476083 | ||
| 035 | |a (PRQ)p1895-2beb88ea046e2b437f01e53cea6a70d0fdb14dccd7841cb19a35ddbe5b272b840 | ||
| 035 | |a (KEY)0120071220150000088000300605riskfactorsforlossofresidualrenalfunctioninchildre | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q DNB |
| 084 | |a 44.88 |2 bkl | ||
| 100 | 1 | |a Ha, Il-Soo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Risk factors for loss of residual renal function in children treated with chronic peritoneal dialysis |
| 264 | 1 | |c 2015 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 520 | |a In dialyzed patients, preservation of residual renal function is associated with better survival, lower morbidity, and greater quality of life. To analyze the evolution of residual diuresis over time, we prospectively monitored urine output in 401 pediatric patients in the global IPPN registry who commenced peritoneal dialysis (PD) with significant residual renal function. Associations of patient characteristics and time-variant covariates with daily urine output and the risk of developing oligoanuria (under 100 ml/m(2)/day) were analyzed by mixed linear modeling and Cox regression analysis including time-varying covariates. With an average loss of daily urine volume of 130 ml/m(2) per year, median time to oligoanuria was 48 months. Residual diuresis significantly subsided more rapidly in children with glomerulopathies, lower diuresis at start of PD, high ultrafiltration volume, and icodextrin use. Administration of diuretics significantly reduced oligoanuria risk, whereas the prescription of renin-angiotensin system antagonists significantly increased the risk oligoanuria. Urine output on PD was significantly associated in a negative manner with glomerulopathies (-584 ml/m(2)) and marginally with the use of icodextrin (-179 ml/m(2)) but positively associated with the use of biocompatible PD fluid (+111 ml/m(2)). Children in both Asia and North America had consistently lower urine output compared with those in Europe perhaps due to regional variances in therapy. Thus, in children undergoing PD, residual renal function depends strongly on the cause of underlying kidney disease and may be modifiable by diuretic therapy, peritoneal ultrafiltration, and choice of PD fluid. | ||
| 540 | |a Nutzungsrecht: Copyright © 2015 International Society of Nephrology 2015 International Society of Nephrology | ||
| 650 | 4 | |a urine volume | |
| 650 | 4 | |a peritoneal dialysis | |
| 650 | 4 | |a oligoanuria | |
| 650 | 4 | |a children | |
| 650 | 4 | |a Clinical Investigation | |
| 650 | 4 | |a registry | |
| 650 | 4 | |a risk factors | |
| 700 | 1 | |a Yap, Hui K |4 oth | |
| 700 | 1 | |a Munarriz, Reyner L |4 oth | |
| 700 | 1 | |a Zambrano, Pedro H |4 oth | |
| 700 | 1 | |a Flynn, Joseph T |4 oth | |
| 700 | 1 | |a Bilge, Ilmay |4 oth | |
| 700 | 1 | |a Szczepanska, Maria |4 oth | |
| 700 | 1 | |a Lai, Wai-Ming |4 oth | |
| 700 | 1 | |a Antonio, Zenaida L |4 oth | |
| 700 | 1 | |a Gulati, Ashima |4 oth | |
| 700 | 1 | |a Hooman, Nakysa |4 oth | |
| 700 | 1 | |a van Hoeck, Koen |4 oth | |
| 700 | 1 | |a Higuita, Lina M S |4 oth | |
| 700 | 1 | |a Verrina, Enrico |4 oth | |
| 700 | 1 | |a Klaus, Günter |4 oth | |
| 700 | 1 | |a Fischbach, Michel |4 oth | |
| 700 | 1 | |a Riyami, Mohammed A |4 oth | |
| 700 | 1 | |a Sahpazova, Emilja |4 oth | |
| 700 | 1 | |a Sander, Anja |4 oth | |
| 700 | 1 | |a Warady, Bradley A |4 oth | |
| 700 | 1 | |a Schaefer, Franz |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Kidney international |d New York, NY : Elsevier, 1972 |g 88(2015), 3, Seite 605-613 |w (DE-627)129291900 |w (DE-600)120573-0 |w (DE-576)014473127 |x 0085-2538 |7 nnns |
| 773 | 1 | 8 | |g volume:88 |g year:2015 |g number:3 |g pages:605-613 |
| 856 | 4 | 1 | |u http://dx.doi.org/10.1038/ki.2015.108 |3 Volltext |
| 856 | 4 | 2 | |u http://www.ncbi.nlm.nih.gov/pubmed/25874598 |
| 856 | 4 | 2 | |u http://search.proquest.com/docview/1708184758 |
| 856 | 4 | 2 | |u http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4558567&tool=pmcentrez&rendertype=abstract |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a GBV_ILN_105 | ||
| 912 | |a GBV_ILN_2006 | ||
| 912 | |a GBV_ILN_2424 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4112 | ||
| 912 | |a GBV_ILN_4219 | ||
| 936 | b | k | |a 44.88 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 88 |j 2015 |e 3 |h 605-613 | ||